5-Azacytidine combined with bone morphogenetic protein 2 induces differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells

doi:10.12307/2022.371

Abstract

Abstract: BACKGROUND: Stem cells have become ideal seed cells in tissue engineering, which provides a research direction for cell transplantation in the treatment of myocardial infarction.
OBJECTIVE: To investigate the feasibility of bone morphogenetic protein 2 combined with 5-azacytidine on the differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells in vitro.
METHODS: Bone marrow mesenchymal stem cells were cultured by whole bone marrow culture adherent method. The third generation of bone marrow mesenchymal stem cells was divided into four groups: control group (ordinary Iscove’s modified Dulbecco’s medium), bone morphogenetic protein 2 group (200 ng/L), 5-azacytidine group (10 µmol/L), 5-azacytidine and bone morphogenetic protein 2 group. After induction for 3 days, the normal medium was changed and cultured for 4 weeks. The expression of cTnI was detected by immunocytochemistry. The expression of Desmin and cTnT was detected by immunofluorescence. The expression of cTnT and cTnI was detected by western blot assay. After 3 days of induction, the normal medium was changed and cultured for 1, 2 and 4 weeks. The mRNA expression of GATA-4 and Nkx2.5 was detected by RT-qPCR.
RESULTS AND CONCLUSION: (1) Western blot assay showed that cTnT and cTnI were expressed in the induction group. The expression levels of cTnT and cTnI in the combined group were higher than those in other groups (P < 0.01). (2) Immunocytochemistry showed positive expression of cardiac troponin (cTnI) in the induction group; the expression was higher in the combined group than that in the induction group (P < 0.05). Immunofluorescence cytochemistry assay showed the positive expression of Desmin and cTnT; the expression in the combined group was higher than that in the induction group (P < 0.05). (3) RT-qPCR showed the mRNA expression of GATA-4 and Nkx2.5 in the induction group; the expression was higher in the combined group than that in the induction group (P < 0.05). (4) The results showed that bone marrow mesenchymal stem cells induced by 5-azacytidine and bone morphogenetic protein 2 could improve the differentiation efficiency of cardiomyocyte-like cells.

Key words: stem cells, bone marrow mesenchymal stem cells, myocardial like cells, bone morphogenetic protein 2, 5-azacytidine, SD rats

CLC Number:

Wang Wenhua, Liu Yang, Wang Qiaomin, Lü Yang, Zhao Yaru, Wang Haiping. 5-Azacytidine combined with bone morphogenetic protein 2 induces differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(19): 2958-2963.

Figures/Tables 8

References

[1] 宋晓玥,程灏,陈璐.间充质干细胞治疗心肌梗死的研究进展[J].中国医学工程,2019,27(6):34-39.
[2] 贾秀丽,李昌平. 5-氮胞苷诱导骨髓间充质干细胞向心肌细胞分化中的作用[J].中国组织工程研究,2016,20(50):7469-7474.
[3] MONZEN K, NAGAI R, KOMURO I. A role for bone morphogenetic protein signaling in cardiomyocyte differentiation. Trends Cardiovasc Med. 2002;12(6):263-269.
[4] GOLPANIAN S, WOLF A, HATZISTERGOS KE, et al. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev. 2016;96(3):1127-1168.
[5] HARE JM, FISHMAN JE, GERSTENBLITH G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22): 2369-2379.
[6] SIMPSON D, LIU H, FAN TH, et al. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007;25(9):2350-2357.
[7] LIU J, HU Q, WANG Z, et al. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol. 2004;287(2):H501-511.
[8] YANG L, YAN F, MA J, et al. Ultrasound-Targeted Microbubble Destruction-Mediated Co-Delivery of Cxcl12 (Sdf-1alpha) and Bmp2 Genes for Myocardial Repair. J Biomed Nanotechnol. 2019;15(6):1299-1312.
[9] MAKINO S, FUKUDA K, MIYOSHI S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103(5): 697-705.
[10] 郭茂娟,范英昌,徐秀梅,等.5-氮胞苷诱导骨髓间充质干细胞向心肌细胞的分化[J].中国组织工程研究与临床康复,2007,11(46): 9238-9241.
[11] 王俊,陈斌,刘翔,等.5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌样细胞分化的实验研究[J].南京医科大学学报(自然科学版), 2012,32(5):631-635.
[12] 王欢,杨曦,魏琴,等.5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌细胞分化的研究[J].新疆医科大学学报,2012,35(12):1590-1594.
[13] XING Y, LV A, WANG L, et al. The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem. 2012;360(1-2): 279-287.
[14] CHOI SC, YOON J, SHIM WJ, et al. 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med. 2004;36(6): 515-523.
[15] POTAPOVA IA, DORONIN SV, KELLY DJ, et al. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am J Physiol Heart Circ Physiol. 2008;295(6):H2257-2263.
[16] WANG YL, ZHANG G, WANG HJ, et al. Preinduction with bone morphogenetic protein-2 enhances cardiomyogenic differentiation of c-kit+ mesenchymal stem cells and repair of infarcted myocardium. Int J Cardiol. 2018;265:173-180.
[17] CHUNG YH, HUANG YH, CHU TH, et al. BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling. Lab Invest. 2018;98(8):999-1013.
[18] WANG S, SUN A, LI L, et al. Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex. J Cell Mol Med. 2012;16(10):2301-2310.
[19] 陈晓依,王浩宇,吕洋,等.PFT-α与BMP-2联合诱导大鼠BMMSCs分化为心肌样细胞[J].基础医学与临床,2018,38(8):1088-1093.
[20] LV Y, GAO CW, LIU B, et al. BMP-2 combined with salvianolic acid B promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Kaohsiung J Med Sci. 2017;33(10):477-485.
[21] 高辰玮,王海萍,吴志刚,等.骨形态发生蛋白2体外诱导大鼠骨髓间充质干细胞向心肌样细胞的分化[J].中国组织工程研究,2012, 16(27):4953-4958.
[22] 侯婧,吕安林,刘博武,等.骨形态蛋白2诱导大鼠骨髓间充质干细胞分化为心肌样细胞的实验研究[J].中华临床医师杂志(电子版), 2012,6(7):27-30.
[23] ABBEY D, SESHAGIRI PB. Aza-induced cardiomyocyte differentiation of P19 EC-cells by epigenetic co-regulation and ERK signaling. Gene. 2013;526(2):364-373.
[24] SHIOZAKI M, INOUE K, SUWA S, et al. Utility of the 0-hour/1-hour high-sensitivity cardiac troponin T algorithm in Asian patients with suspected non-ST elevation myocardial infarction. Int J Cardiol. 2017;249:32-35.
[25] MUELLER C, GIANNITSIS E, CHRIST M, et al. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. Ann Emerg Med. 2016;68(1):76-87.
[26] APPLE FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta. 1999;284(2):151-159.
[27] HNIA K, RAMSPACHER C, VERMOT J, et al. Desmin in muscle and associated diseases: beyond the structural function. Cell Tissue Res. 2015;360(3):591-608.
[28] YU B, GONG M, WANG Y, et al. Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles. PLoS One. 2013;8(8):e73304.
[29] CAREY AS, LIANG L, EDWARDS J, et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet. 2013;6(5):444-451.